Results 141 to 150 of about 48,655 (256)

Editorial: Electrochemiluminescence: From Fundamentals to Applications

Frontiers in Chemistry, 2021
Fabio Rizzo, Fabio Rizzo, Federico Polo, Neso Sojic, Guobao Xu, Guobao Xu   +5 more
doaj   +1 more source

A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis. [PDF]

, 2018
The only currently commercialized point-of-care assay for tuberculosis (TB) that measures lipoarabinomannan (LAM) in urine (Alere LF-LAM) has insufficient sensitivity.
Broger, Tobias, Choudhary, Alok, Denkinger, Claudia M, Honnen, William J, Katsuragi, Kiyonori, Kawasaki, Masanori, Li, Andra, Lowary, Todd L, Mathew, Anu, Nahid, Payam, Pinter, Abraham, Plisova, Tatiana, Shen, Ke, Sigal, George B, Tsionsky, Michael, Zheng, Ruixiang Blake   +15 more
core  

electrochemiluminescence assay

Citation: 'electrochemiluminescence assay' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.14127 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms ...
openaire   +1 more source

Synchronized Electro‐Chromo‐Emissive Devices Using a Mixed Ionic‐Electronic Conductive Layer for XR Applications

Advanced Functional Materials, Volume 36, Issue 13, 12 February 2026.
A single cell type Electro‐chromo‐emissive (ECECL) device integrating synchronized electrochromic (EC) and electrochemiluminescent (ECL) functions is developed using a mixed ionic‐electronic conductor (MIEC). A MIEC layer reduces ionic/electronic resistance, enabling ultrafast switching and enhanced optical contrast.
Hwandong Jang, Sienoh Park, Won‐Jae Joo, Jinbo Kim, Nori Kobayashi, Eunkyoung Kim   +5 more
wiley   +1 more source

AI‐Assisted Bioelectronics for Personalized Health Management

Advanced Electronic Materials, Volume 12, Issue 3, 4 February 2026.
Recent advances in artificial intelligence (AI)‐assisted bioelectronics, including materials, device fabrication, working mechanisms, AI‐hardware integration, and proof‐of‐concept applications in digital health management, are summarized. The emergence of AI‐assisted bioelectronic systems and potential solutions to existing challenges are discussed ...
Huiwen Xiong, Changhao Dai, Xuting Chen, Jilie Kong, Dacheng Wei, Xueen Fang, Wenhao Weng   +6 more
wiley   +1 more source

Peptide and Drug‐Protected Gold Nanoclusters as Promising Biomaterials: Synthesis, Properties, and Applications

Aggregate, Volume 7, Issue 2, February 2026.
The integration of atomically precise gold nanoclusters with peptides or drugs represents a cutting‐edge class of nanomaterials in the biomedical field, owing to their unique physicochemical properties such as water solubility, excellent biocompatibility, low toxicity, and good renal clearance.
Rebeca Garcia Moura, M. Terêsa Machini, Rongchao Jin   +2 more
wiley   +1 more source

Electrochemiluminescence Sensing

Analytical Sciences, 2020
openaire   +3 more sources

Electrochemiluminescence [PDF]

, 2020
openaire   +1 more source

The Marriage of Metal Nanoclusters With Reticular Frameworks: Synthetic Strategies and Biomedical Applications

Aggregate, Volume 7, Issue 2, February 2026.
The integration of metal nanoclusters (MNCs) with reticular frameworks (RFs) has recently emerged as a powerful strategy to create composite materials with enhanced and synergistic functionalities. This review provides an overview of the synthetic strategies developed for constructing MNCs/RFs composites and their recent advances in biomedical ...
Wenfeng Liu, Qinyin Yin, Li‐Li Tan, Li Shang   +3 more
wiley   +1 more source

Distinct alterations of adiponectin, fibroblast growth factor 21 (FGF‐21), and insulin‐like growth factor binding protein 2 (IGFBP‐2) link dysmetabolism with cognitive decline across the Alzheimer's disease spectrum

Alzheimer's &Dementia, Volume 22, Issue 2, February 2026.
Abstract INTRODUCTION Metabolic disorders are risk factors for Alzheimer's disease (AD), although underlying mechanisms remain unclear. We investigated the relationship between peripheral metabolic markers – adiponectin, fibroblast growth factor 21 (FGF‐21), and insulin‐like growth factor binding protein 2 (IGFBP‐2) – and AD.
Caroline Dallaire‐Théroux, Helena L. Denis, Rosalie Cottez, Cyntia Tremblay, Amélie Provencher, Josue Valentin‐Escalera, Manon Leclerc, Andreanne Loiselle, Marine Tournissac, Olivier Potvin, Sylvie Belleville, Anne Gangloff, Frederic Picard, Henrik Zetterberg, Consortium for the Early Identification of Alzheimer's Disease – Quebec (CIMA‐Q), Frédéric Calon   +15 more
wiley   +1 more source